Latest updates from Early is Good
October 24, 2024 Press Release
Early is Good has received a $1.6M NIH Phase 2 grant to support validation efforts of its bladder cancer monitoring test, BCDx.
April 9, 2024 Press Release
EIG announces a collaboration with Mayo Clinic to develop a comprehensive liquid biopsy for men with advanced prostate cancer.
November 2, 2022 Press Release
Early is Good closes a $4 million seed round from Social Capital led by Chamath Palihapitiya to advance BCDx clinical trials.
July 31, 2023 Event
EIG's founder presents BCDx, a breakthrough in bladder cancer diagnosis, at the American Chemical Society meeting.